[
  {
    "ts": null,
    "headline": "Edwards Lifesciences: Double-Digit Top Line And EPS Growth Ahead",
    "summary": "Despite a solid Q4 earnings beat, Edwards Lifesciences' shares remain undervalued with a reduced P/E multiple of 33x. Read why EW stock is a Buy.",
    "url": "https://finnhub.io/api/news?id=d81647b7dd040395e6f1307cc4ca2dfc0f65d01a7f2cdee46d11225ed894b209",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742687473,
      "headline": "Edwards Lifesciences: Double-Digit Top Line And EPS Growth Ahead",
      "id": 133322437,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1642214923/image_1642214923.jpg?io=getty-c-w1536",
      "related": "EW",
      "source": "SeekingAlpha",
      "summary": "Despite a solid Q4 earnings beat, Edwards Lifesciences' shares remain undervalued with a reduced P/E multiple of 33x. Read why EW stock is a Buy.",
      "url": "https://finnhub.io/api/news?id=d81647b7dd040395e6f1307cc4ca2dfc0f65d01a7f2cdee46d11225ed894b209"
    }
  }
]